
Intervet Dexafort suspension for allergic and autoimmune diseases in cattle, sheep, goats, dogs and cats 50 ml
- Pickup from our store13 Mala Arnautska St · 1–3 days1–3 daysfree
- Nova Poshta: branch or lockerdispatched tomorrow · 1–5 work days1–5 work daysNP ratesfree from ₴1370
- Brand
- Intervet
- Product type
- Medicines and supplements
- Animal
- For dogs, For cats, For cattle, For MRS
- Brand registration country
- Netherlands
Intervet Dexafort suspension for allergic and autoimmune diseases in cattle, small ruminants, dogs and cats, 50 ml
Dexafort is a hormonal veterinary medicine containing, per 1 ml, the active substances 2.67 mg dexamethasone phenylpropionate and 1.32 mg dexamethasone sodium phosphate, as well as the excipients:
- 4.0 mg sodium chloride,
- 11.4 mg sodium citrate,
- 10.4 mg benzyl alcohol,
- 0.4 mg methylcellulose MH 50,
- water for injections to 1 ml.
A sterile white aqueous suspension for injection.
A sediment may form during storage; it disperses into a uniform suspension when shaken.
Supplied in 50 ml glass vials packed in cardboard boxes.
Pharmacological properties
The dexamethasone in the product is a synthetic analogue of cortisol, a glucocorticosteroid hormone of the adrenal cortex.
It has a more pronounced glucocorticosteroid effect and has anti-inflammatory, anti-oedema, desensitising and anti-allergic effects.
The hormone works by inhibiting the release of inflammatory mediators from eosinophils and mast cells.
Dexamethasone acts on every stage of the inflammatory process: it inhibits the synthesis of prostaglandins at the arachidonic acid level and of "pro-inflammatory cytokines" (interleukin 1, tumour necrosis factor alpha, etc.), and increases cell membrane resistance to various damaging factors.
Dexafort stimulates the steroid receptors of lymphocytes, promoting the formation of lipocortins with anti-oedema activity.
Suppresses lymphoid tissue proliferation and cell-mediated immunity and disrupts T-lymphocyte kinetics, reducing their cytotoxic activity.
B lymphocytes are more resistant to glucocorticoids, but high doses lower immunoglobulin concentrations, due to an initial increase in their catabolism and subsequent inhibition of synthesis.
Dexafort acts quickly and has a long-lasting effect.
After intramuscular injection, dexamethasone sodium phosphate is rapidly absorbed from the injection site.
Dexamethasone phenylpropionate is absorbed more slowly and provides a long-lasting effect.
The peak plasma concentration of dexamethasone is reached after 60 minutes.
The therapeutic serum concentration is maintained for 30 - 96 hours depending on the animal species.
Bioavailability after intramuscular injection is 100 %.
Dexamethasone is biotransformed in the liver and partly in fibroblasts involved in metabolism.
The metabolites are excreted mainly in faeces and urine.
Indications
Prescribed for cattle, horses, pigs, sheep, goats, dogs and cats to treat inflammatory processes and diseases of allergic and autoimmune origin (allergic dermatitis, eczema, post-traumatic swelling, bronchial asthma, joint diseases, acute mastitis).
Dosage and administration
Dexafort is given to cattle, horses, pigs, sheep and goats intramuscularly, and to dogs and cats intramuscularly or subcutaneously, once, at the following doses:
- cattle and horses - 10 ml,
- calves, foals, sheep, goats and pigs - 1 - 3 ml,
- dogs - 0.5 - 1 ml,
- cats - 0.25 - 0.5 ml.
If necessary, the product is reapplied after 7 days.
Before each use, the vial of Dexafort is shaken thoroughly to obtain a uniform suspension.
When treating inflammation complicated by pathogenic and opportunistic bacterial microflora, Dexafort is prescribed only in combination with broad-spectrum antibacterial medicines.
Adverse effects
Polyuria (increased urine production), polydipsia (intense, unquenchable thirst) and polyphagia (excessive food intake) may occur.
Long-term use may cause Cushing's syndrome, clinically shown by severe thirst, frequent urination with incontinence both day and night, extensive symmetrical hair loss, increased appetite, drowsiness, muscle weakness, a pendulous abdomen, weight loss and osteoporosis.
The use of corticosteroids in lactating cows may cause a temporary drop in milk yield.
Using corticosteroids to induce labour may reduce foetal viability and increase cases of retained placenta.
Contraindications
Increased individual sensitivity to the components of the product. Dexafort must not be used in pregnant animals in the last trimester of pregnancy, as this may lead to premature birth or abortion.
Do not give the product at the same time as vaccines due to the immunosuppressive effect of corticosteroids.
Do not use in animals with viral or fungal diseases, diabetes, osteoporosis, hyperadrenocorticism, kidney disease or heart failure.
Dexafort should be given with great caution to pregnant animals in the first and second trimesters.
Special instructions
Cattle may be slaughtered for meat 48 days, and horses 24 days, after the last treatment.
Milk from cows must not be used for human consumption for 5 days after the last administration; such milk may be fed to animals after heat treatment.
Meat from animals slaughtered before the specified period may be used to produce meat and bone meal.
Storage conditions
With caution as a List B substance. In a dry place protected from light and out of reach of children and animals, at 15 to 25 °C.
Shelf life - 5 years.
Once the vial is opened, the medicinal product should be used within 8 weeks, observing aseptic rules.
Reviews
No reviews yet
Be the first to review this product.
Related products
More from this brand — Intervet
All brand products →













